Finland· FI-REL-REL42494
Zevtera
A ceftobiprol medocaril product containing ceftobiprole medocaril sodium, registered in Finland by Basilea Pharmaceutica Deutschland GmbH. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ceftobiprol medocaril is registered in 8 of 19 countries.
Countries holding a registration under ATC J01DI01 (ceftobiprol medocaril), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Ceftobiprol medocaril · ATC J01DI01
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Ceftobiprole medocaril sodium
- Manufacturer
- Basilea Pharmaceutica Deutschland GmbH
- Country
- Finland (FI)
- ATC code
- J01DI01
- ATC class
- Ceftobiprol medocaril
- Defined daily dose
- 1.5 g, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftobiprol medocaril in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMabelio 500 mgBasilea Medical
- IrelandAdaluzis 500mg Powder for concentrate for solution for infusionAdvanz Pharma Limited
- NorwayZevteraBasilea Pharmaceutica Deutschland GmbH
- SwedenZevtera 500 mg Pulver till koncentrat till infusionsvätska, lösningBasilea Pharmaceutica Deutschland GmbH
- United StatesZEVTERALa Jolla Pharmaceutical Company
- GermanyZevteraAdvanz Pharma Limited
- FranceMABELIO 500 mg, poudre pour solution à diluer pour solution pour perfusionADVANZ PHARMA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Zevtera
- Germany · Zevtera
- Denmark · Zevtera
- Spain · Zevtera
- France · Mabelio
- United Kingdom (Northern Ireland) · Zevtera
- Ireland · Adaluzis
- Italy · Mabelio
- Luxembourg · Mabelio, Zevtera
- Norway · Zevtera
- Poland · Zevtera
- Portugal · Zevtera
- Sweden · Zevtera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/801c4950-6c91-42bb-a199-2f6808dcadd4 GET /v1/drugs/801c4950-6c91-42bb-a199-2f6808dcadd4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.5",
"form": "kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos",
"route": "Laskimoon",
"ddd_unit": "g",
"strength": "500 mg",
"atc_label": "keftobiprolimedokariili",
"ma_number": "31005",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL42494",
"authorised_at": "2014-01-24"
}See everything about ceftobiprol medocaril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.